Deutsche Bank’s PharMerica Corporation PMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-964,722
| Closed | -$28.3M | – | 5302 |
|
|
2017
Q3 | $28.3M | Buy |
964,722
+488,030
| +102% | +$13.7M | 0.02% | 812 |
|
|
2017
Q2 | $12.5M | Sell |
476,692
-42,929
| -8% | -$1.06M | 0.01% | 1233 |
|
|
2017
Q1 | $12.2M | Buy |
519,621
+13,769
| +3% | +$340K | 0.01% | 1139 |
|
|
2016
Q4 | $12.7M | Sell |
505,852
-176,797
| -26% | -$4.46M | 0.01% | 1108 |
|
|
2016
Q3 | $19.2M | Buy |
682,649
+105,328
| +18% | +$2.7M | 0.01% | 943 |
|
|
2016
Q2 | $14.2M | Buy |
577,321
+45,606
| +9% | +$1.13M | 0.01% | 1092 |
|
|
2016
Q1 | $11.8M | Sell |
531,715
-51,977
| -9% | -$1.38M | 0.01% | 1165 |
|
|
2015
Q4 | $20.4M | Sell |
583,692
-42,380
| -7% | -$1.33M | 0.01% | 907 |
|
|
2015
Q3 | $17.8M | Sell |
626,072
-26,011
| -4% | -$874K | 0.01% | 955 |
|
|
2015
Q2 | $21.7M | Buy |
652,083
+289,896
| +80% | +$8.9M | 0.01% | 890 |
|
|
2015
Q1 | $10.2M | Buy |
362,187
+199,956
| +123% | +$4.97M | 0.01% | 1322 |
|
|
2014
Q4 | $3.36M | Buy |
162,231
+80,605
| +99% | +$1.91M | ﹤0.01% | 2271 |
|
|
2014
Q3 | $1.99M | Buy |
81,626
+13,725
| +20% | +$364K | ﹤0.01% | 2532 |
|
|
2014
Q2 | $1.94M | Sell |
67,901
-24,878
| -27% | -$692K | ﹤0.01% | 2456 |
|
|
2014
Q1 | $2.6M | Buy |
92,779
+16,914
| +22% | +$415K | ﹤0.01% | 2234 |
|
|
2013
Q4 | $1.63M | Buy |
75,865
+3,217
| +4% | +$58.5K | ﹤0.01% | 2381 |
|
|
2013
Q3 | $961K | Sell |
72,648
-319,471
| -81% | -$4.3M | ﹤0.01% | 3003 |
|
|
2013
Q2 | $5.43M | Buy |
+392,119
| New | +$5.56M | ﹤0.01% | 1572 |
|
Deutsche Bank's PMC Position: Q4 2017 in Review
Deutsche Bank sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 964,722 shares — an estimated $28.3M sold.
Deutsche Bank first reported a position in PMC in Q2 2013 and held it in 18 quarters. The position peaked at $28.3M in Q3 2017. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.
- Deutsche Bank reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
- Deutsche Bank sold 964,722 PharMerica Corporation shares in Q4 2017, an estimated $28.3M.
- Deutsche Bank first reported a position in PharMerica Corporation in Q2 2013 and held it in 18 quarters.
- Deutsche Bank's PharMerica Corporation position peaked at $28.3M in Q3 2017.
- 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.
Based on Deutsche Bank's 13F filing for Q4 2017, filed 14 Feb 2018.